Sang Teak Jung

17PUBLICATIONS
30CO-AUTHORS
Chemical engineering designGlycoconjugatesMedical molecular engineering of nucleic acids and proteinsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 14, 2025
Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular Docking-Based Binding Mode Analysis.

Inji Jung, Dinesh Kumar Sriramulu, Sun-Gu Lee

|Jul 24, 2025
Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies.

Inji Jung, Dinesh Kumar Sriramulu, Jeong Hyeon Yoon

|Jul 26, 2024
Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.

Jisun Lee, Bomi Kim, Hye-Min Woo

|Jul 01, 2024
An epidermal growth factor receptor-targeting immunotoxin based on IgG shows potent antitumor activity against head and neck cancer.

Mei Huang, Jisoo Park, Jina Seo

|Jul 24, 2023
Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments.

Wonju Lee, Sang Min Lee, Sang Taek Jung

|Mar 10, 2023
Glycan-Controlled Human PD-1 Variants Displaying Broad-Spectrum High Binding to PD-1 Ligands Potentiate T Cell.

Ji Yeon Ha, Kwang-Jin Chun, Sanghwan Ko

Pageof 3

Frequent Collaborators

3 joint publications

Jung-Hyun Na

2 joint publications

Sun-Gu Lee

1 joint publications

Hyungdon Yun

1 joint publications

Suyeon Kim